Hyperglycemia  >>  Linjeta (prandial insulin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Linjeta (prandial insulin) / Ipsen
NCT01067118: A Randomized Control Trial Comparing Linjeta Versus Humalog in Pumps: Effect on Postprandial Blood Sugars.

Withdrawn
2
0
US
LINjeta U-100 Insulin, VIAject U-100, Humalog U-100, Lispro U-100 insulin
Stanford University, Biodel, University of Colorado, Denver
Diabetes Mellitus
01/11
06/11

Download Options